I 

118TH CONGRESS 

2D SESSION H. R. 9445 

To direct the Secretary of Defense to replace certain syringes of the 

Department of Defense. 

IN THE HOUSE OF REPRESENTATIVES 

AUGUST 30, 2024 

Ms. SHERRILL introduced the following bill; which was referred to the 

Committee on Armed Services 

A BILL 

To direct the Secretary of Defense to replace certain syringes 

of the Department of Defense. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Safe Military Medical 

5 Equipment Act’’. 

6 SEC. 2. PLAN FOR IDENTIFYING AND REPLACING SYRINGES 

7 OF CONCERN. 

8 (a) IN GENERAL.—Not later than 180 days after the 

9 date of the enactment of this Act, the Secretary of De10 fense, in coordination with the Director of the Defense LoVerDate Sep 11 2014 04:01 Sep 11, 2024 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H9445.IH H9445

kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 9445 IH

1 gistics Agency and the Director of the Defense Health 

2 Agency, shall develop and implement a plan to review all 

3 medical syringes in the inventories and stockpiles of the 

4 Department of Defense and current and planned acquisi5 tions of the Department to— 

6 (1) identify medical syringes that have been 

7 subject to a Food and Drug Administration Import 

8 Alert or meet the conditions of a Food and Drug 

9 Administration Safety Communication; and 

10 (2) replace such medical syringes with medical 

11 syringes produced domestically or produced in part12 ners or allies of the United States. 

13 (b) COORDINATED PLAN CONTENTS.—The Secretary 

14 of Defense shall include in the plan required under sub15 section (a) the following: 

16 (1) An identification of any medical syringes in 

17 the inventories and stockpiles of the Department of 

18 Defense and which the Department is acquiring or 

19 plans to acquire that have been subject to a Food 

20 and Drug Administration Import Alert or meet the 

21 conditions of a Food and Drug Administration Safe22 ty Communication made in the past five years. 

23 (2) A process for the Department of Defense to 

24 replace the medical syringes described in paragraph 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 9445 IH

1 (1) that are in the inventories and stockpiles of the 

2 Department with those that— 

3 (A) are produced domestically or in part4 ners or allies of the United States; 

5 (B) are not subject to an Import Alert de6 scribed in such paragraph; and 

7 (C) do not meet the conditions of a Safety 

8 Communication described in such paragraph. 

9 (3) A process for the Department of Defense to 

10 cease the acquisition of medical syringes described in 

11 paragraph (1) and ensure that the Department ac12 quires only medical syringes that— 

13 (A) are produced domestically or in part14 ners or allies of the United States; 

15 (B) are not subject to an Import Alert de16 scribed in such paragraph; and 

17 (C) do not meet the conditions of a Safety 

18 Communication described in such paragraph. 

19 (4) A process enabling the Department of De20 fense to— 

21 (A) track Food and Drug Administration 

22 Import Alerts and Safety Communications re23 garding medical syringes; 

24 (B) review the inventories, stockpiles, and 

25 current and planned acquisitions of the DepartVerDate Sep 11 2014 04:01 Sep 11, 2024 Jkt 049200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H9445.IH H9445

kjohnson on DSK7ZCZBW3PROD with $$_JOB
4 

•HR 9445 IH

1 ment for medical syringes that are subject to 

2 such Import Alerts or that meet the conditions 

3 of such Safety Communications; and 

4 (C) replace such medical syringes with 

5 medical syringes that are produced domestically 

6 or produced in partners or allies of the United 

7 States. 

8 (c) REPORT.—Upon developing the plan required by 

9 subsection (a), the Secretary of Defense shall submit to 

10 the Committees on Armed Services of the Senate and the 

11 House of Representatives a report describing such plan, 

12 including— 

13 (1) the number of medical syringes, if any, in 

14 the inventories and stockpiles of the Department of 

15 Defense that have been subject to a Food and Drug 

16 Administration Import Alert or meet the conditions 

17 of a Food and Drug Administration Safety Commu18 nication made in the past five years; 

19 (2) a description of any planned or ongoing ac20 quisition by the Department of medical syringes that 

21 have been subject to a Food and Drug Administra22 tion Import Alert or meet the conditions of a Food 

23 and Drug Administration Safety Communication 

24 made in the past five years, including acquisitions 

25 with respect to which contracts have not yet been 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
5 

•HR 9445 IH

1 awarded and existing agreements under which such 

2 syringes may be acquired for the Department; 

3 (3) for medical syringes described in paragraph 

4 (1) or with respect to which the Department is car5 rying out an acquisition described in paragraph (2), 

6 the product name, manufacturer, and country of ori7 gin; and 

8 (4) an explanation of the process described in 

9 subsection (b)(4) that will be implemented under 

10 such plan. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB